AMOEBA SAS (ALMIB.PA) Stock Overview
Europe - EPA:ALMIB - FR0011051598 - Common Stock
ALMIB.PA Key Statistics, Chart & Performance
The current stock price of ALMIB.PA is 1.108 EUR. In the past month the price increased by 14.82%. In the past year, price increased by 78.71%.
ALMIB.PA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| GIN.DE | GIVAUDAN-REG | 27.15 | 33.81B | ||
| SIKA.DE | SIKA AG-REG | 20.75 | 27.40B | ||
| NZM2.DE | NOVONESIS (NOVOZYMES) B | 76.66 | 21.29B | ||
| DSFIR.AS | DSM-FIRMENICH AG | 77.85 | 19.44B | ||
| BRG.OL | BORREGAARD ASA | 21.17 | 18.80B | ||
| ELK.OL | ELKEM ASA | N/A | 17.29B | ||
| 1COV.DE | COVESTRO AG | N/A | 11.16B | ||
| SY1.DE | SYMRISE AG | 20.32 | 10.31B | ||
| AKZA.AS | AKZO NOBEL N.V. | 19.58 | 9.95B | ||
| AMC.DE | ALBEMARLE CORP | N/A | 10.09B | ||
| SYENS.BR | SYENSQO SA | 18.76 | 7.27B | ||
| EVK.DE | EVONIK INDUSTRIES AG | 8.87 | 6.91B |
Related stock screener links
About ALMIB.PA
Company Profile
Amoéba SA.is a lyonnaise greentech company based on chassieu whose ambition is to become a major player in the treatment of microbiological risk based on the patented use of amoebae in the plant protection and cosmetics sectors. The company is headquartered in Chassieu, Auvergne-Rhone-Alpes and currently employs 18 full-time employees. The company went IPO on 2015-07-10. The firm specializes in disruptive biological solutions for the treatment of Legionella, amoeba and biofilm in water. The firm's offering includes products and services, such as: Cleantech biological solution, a patented technological disruptive product with no impact on the environment; amoebic analyses of waters of wet cooling towers (TAR), hot sanitary waters, industrial waters and waters of swimming pools; as well as Legionella tests of industrial waste water, among others. The firm is engaged in various technical, commercial, industrial and investment partnerships.
Company Info
AMOEBA SAS
38 avenue des Freres Montgolfier
Chassieu AUVERGNE-RHONE-ALPES FR
Employees: 20
Phone: 33426691600
AMOEBA SAS / ALMIB.PA FAQ
Can you describe the business of AMOEBA SAS?
Amoéba SA.is a lyonnaise greentech company based on chassieu whose ambition is to become a major player in the treatment of microbiological risk based on the patented use of amoebae in the plant protection and cosmetics sectors. The company is headquartered in Chassieu, Auvergne-Rhone-Alpes and currently employs 18 full-time employees. The company went IPO on 2015-07-10. The firm specializes in disruptive biological solutions for the treatment of Legionella, amoeba and biofilm in water. The firm's offering includes products and services, such as: Cleantech biological solution, a patented technological disruptive product with no impact on the environment; amoebic analyses of waters of wet cooling towers (TAR), hot sanitary waters, industrial waters and waters of swimming pools; as well as Legionella tests of industrial waste water, among others. The firm is engaged in various technical, commercial, industrial and investment partnerships.
Can you provide the latest stock price for AMOEBA SAS?
The current stock price of ALMIB.PA is 1.108 EUR. The price increased by 1.09% in the last trading session.
Does ALMIB stock pay dividends?
ALMIB.PA does not pay a dividend.
What is the ChartMill technical and fundamental rating of ALMIB stock?
ALMIB.PA has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
Can you provide the sector and industry classification for AMOEBA SAS?
AMOEBA SAS (ALMIB.PA) operates in the Materials sector and the Chemicals industry.
What is the employee count for ALMIB stock?
AMOEBA SAS (ALMIB.PA) currently has 20 employees.
Can you provide the market cap for AMOEBA SAS?
AMOEBA SAS (ALMIB.PA) has a market capitalization of 76.36M EUR. This makes ALMIB.PA a Micro Cap stock.
ALMIB.PA Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to ALMIB.PA. When comparing the yearly performance of all stocks, ALMIB.PA is one of the better performing stocks in the market, outperforming 96.02% of all stocks.
ALMIB.PA Financial Highlights
Over the last trailing twelve months ALMIB.PA reported a non-GAAP Earnings per Share(EPS) of -0.13. The EPS increased by 54.2% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -116.64% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
ALMIB.PA Forecast & Estimates
11 analysts have analysed ALMIB.PA and the average price target is 1.53 EUR. This implies a price increase of 38.09% is expected in the next year compared to the current price of 1.108.